furosemide has been researched along with Bladder Cancer in 12 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Excerpt | Relevance | Reference |
---|---|---|
"An MDR bladder cancer cell line (MGH-u 1R) and its parental (drug sensitive) clone were exposed to epirubicin and furosemide, with the concentration of one drug fixed and that of the other serially diluted in a 96-well plate format." | 7.73 | Furosemide reverses multidrug resistance status in bladder cancer cells in vitro. ( Cooper, AJ; Featherstone, JM; Lwaleed, BA; Sallis, BJ; Speers, AG, 2006) |
"Twenty-two bladder cancer patients underwent F-FDG PET/MRI, using intravenous furosemide and oral hydration for bladder clearance." | 3.85 | Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI. ( Balar, AV; Friedman, KP; Huang, WC; Jackson, K; Ponzo, F; Raad, RA; Rosenkrantz, AB, 2017) |
"An MDR bladder cancer cell line (MGH-u 1R) and its parental (drug sensitive) clone were exposed to epirubicin and furosemide, with the concentration of one drug fixed and that of the other serially diluted in a 96-well plate format." | 3.73 | Furosemide reverses multidrug resistance status in bladder cancer cells in vitro. ( Cooper, AJ; Featherstone, JM; Lwaleed, BA; Sallis, BJ; Speers, AG, 2006) |
"Twenty one patients with advanced bladder cancer (metastases and/or loco-regional recurrences) were treated by cisplatin-based chemotherapy (cisplatin, adriamycin, cyclo-phosphamide (8 patients), cisplatin, methotrexate (8 patients) and cisplatin and radiotherapy (5 patients)." | 3.67 | [Systemic cisplatin-based chemotherapy in the treatment of advanced bladder cancer]. ( Boccon-Gibod, L; Cressey-Kanoui, C; Debré, B; Guinet, F; Steg, A, 1985) |
"Furosemide challenge has the potential to noninvasively resolve the inherent (18)F-FDG contrast handicap in the lower urinary tract." | 1.33 | Forced diuresis improves the diagnostic accuracy of 18F-FDG PET in abdominopelvic malignancies. ( Castaldo, S; Delaloye, AB; Delaloye, JF; Jichlinski, P; Kamel, EM; Leisinger, HJ; Malterre, J; Meuwly, JY; Prior, JO; Vaucher, L, 2006) |
"The second woman had serious orthostatic hypotension because of a pharmacodynamic interaction between three different antihypertensives." | 1.32 | [Adverse drug reactions in three older patients, even without changes in medication]. ( Mannesse, CK; van der Cammen, TJ, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (41.67) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 2 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rosenkrantz, AB | 1 |
Friedman, KP | 1 |
Ponzo, F | 1 |
Raad, RA | 1 |
Jackson, K | 1 |
Huang, WC | 1 |
Balar, AV | 1 |
Nijjar, S | 1 |
Patterson, J | 1 |
Ducharme, J | 1 |
Leslie, WD | 1 |
Demeter, SJ | 1 |
Mannesse, CK | 1 |
van der Cammen, TJ | 1 |
Liu, IJ | 1 |
Segall, GM | 1 |
Nino-Murcia, M | 1 |
Terris, MK | 1 |
Speers, AG | 1 |
Lwaleed, BA | 1 |
Featherstone, JM | 1 |
Sallis, BJ | 1 |
Cooper, AJ | 1 |
Kamel, EM | 1 |
Jichlinski, P | 1 |
Prior, JO | 1 |
Meuwly, JY | 1 |
Delaloye, JF | 1 |
Vaucher, L | 1 |
Malterre, J | 1 |
Castaldo, S | 1 |
Leisinger, HJ | 1 |
Delaloye, AB | 1 |
Pliss, GB | 1 |
Rometti, A | 1 |
Valla, JS | 1 |
Shibata, MA | 1 |
Hagiwara, A | 1 |
Tamano, S | 1 |
Ono, S | 1 |
Fukushima, S | 1 |
Boccon-Gibod, L | 1 |
Guinet, F | 1 |
Cressey-Kanoui, C | 1 |
Debré, B | 1 |
Steg, A | 1 |
Taylor, A | 1 |
Bedont, R | 1 |
Raabe, R | 1 |
Jameson, RM | 1 |
2 trials available for furosemide and Bladder Cancer
Article | Year |
---|---|
The effect of furosemide dose timing on bladder activity in oncology imaging with 18F-fluorodeoxyglucose PET/CT.
Topics: Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Image Interpre | 2010 |
Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of transitional cell carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Diuretics; Fluorodeoxyglucose F18; Furosemide | 2003 |
10 other studies available for furosemide and Bladder Cancer
Article | Year |
---|---|
Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI.
Topics: Aged; Carcinoma, Transitional Cell; Diuresis; Diuretics; Female; Fluorodeoxyglucose F18; Furosemide; | 2017 |
[Adverse drug reactions in three older patients, even without changes in medication].
Topics: Adverse Drug Reaction Reporting Systems; Aged; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non | 2003 |
Furosemide reverses multidrug resistance status in bladder cancer cells in vitro.
Topics: Antibiotics, Antineoplastic; Cell Death; Cell Division; Dose-Response Relationship, Drug; Drug Resis | 2006 |
Forced diuresis improves the diagnostic accuracy of 18F-FDG PET in abdominopelvic malignancies.
Topics: Adult; Diuresis; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Male; Middle Aged; Neoplasm Sta | 2006 |
[New experimental oncologic studies on prevention of bladder cancer].
Topics: Animals; Chlorthalidone; Diuresis; Furosemide; Glucuronidase; Rats; Sodium Nitrite; Sodium Selenite; | 1993 |
[Value of peroperative furosemide in urinary surgery].
Topics: Diverticulum; Furosemide; Humans; Hydronephrosis; Male; Postoperative Care; Prostatic Hyperplasia; U | 1976 |
Lack of a modifying effect by the diuretic drug furosemide on the development of neoplastic lesions in rat two-stage urinary bladder carcinogenesis.
Topics: Animals; Butylhydroxybutylnitrosamine; Cell Transformation, Neoplastic; Cocarcinogenesis; Furosemide | 1989 |
[Systemic cisplatin-based chemotherapy in the treatment of advanced bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclopho | 1985 |
Prolonged half-life following diuretic radionuclide urography as evidence of ureteral obstruction.
Topics: Aged; Furosemide; Half-Life; Humans; Kidney Pelvis; Male; Prostatic Neoplasms; Radionuclide Imaging; | 1985 |
A regime for urinary tract surgery.
Topics: Aged; Aminocaproates; Blood Transfusion; Diuresis; Furosemide; Hemorrhage; Humans; Kidney; Male; Man | 1971 |